Nicotine modulates the neurotoxic effect of β-amyloid protein(25-35) in hippocampal cultures

NeuroReport

Volumn 8, Issue 2, 1997, Pages 513-517

  Zamani, M Reza ^a   Allen, Yvonne S ^b   Owen, Gill P ^a   Gray, Jeffrey A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Mecamylamine; Neuroprotection; Neurotoxicity; Nicotine; Rat hippocampus; AP(25 35)

Indexed keywords

AMYLOID BETA PROTEIN; MECAMYLAMINE; NEUROPROTECTIVE AGENT; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HIPPOCAMPUS; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING;

EID: 0030937773     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199701200-00027     Document Type: Article

References (30)

1. Bharucha NE, Stokes L, Schoenberg BS et al. Neurology 36, 284-288 (1986).
2. van Duijn CM and Hofman A. Br Med J 302, 1491-1494 (1991).
3. Janson AM and Moller A. Neuroscience 57, 931-941 (1993).
4. Behmand RA and Harik SI. J Neurochem 58, 776-779 (1992).
5. Marin P, Maus M, Desagher S et al. Neuroreport 5, 1977-1980 (1994).
6. Akaike A, Tamura Y, Yokota et al. Brain Res 644, 181-187 (1994).
7. Rogers AT and Wonnacott S. Biochem Soc Transact 22, 48S (1994).
8. Barrantes GE, Rogers AT, Lindstrom J et al. Brain Res 672, 228-236 (1995).
9. Lehmann J, Nagy JI, Atmadia S et al. Neuroscience 5, 1161-1174 (1980).
10. Candy JM, Perry RH, Perry EK et al. J Neurol Sci 59, 277-289 (1983).
11. Flynn DD and Mash DC. J Neurochem 47, 1948-1954 (1986).
12. Davies P and Maloney AJF. Lancet ii, 1403 (1976).
13. Schroder H, Giacobini E, Struble RG et al. Neurobiol Ageing 12, 259-262 (1991).
14. Mash DC, Flynn DD and Porter LT. Science 228, 1115-1117 (1985).
15. London ED, Ball MJ and Waller SB. Neurochem Res 14, 745-750 (1989).
16. Rinne JO, Myllykyla T, Lonnberg P et al. Brain Res 547, 167-170 (1991).
17. Yankner BA, Dawes LR, Fisher S et al. Science 245, 417-420 (1989).
18. Mattson MP, Cheng B, Davis D et al. J Neurosci 12, 376-389 (1992).
19. Arispe N, Pollard HB and Rojas E. Mol Cell Biochem 140, 119-125 (1994).
20. Brorson JR, Bindokas VP, Iwama T et al. J Neurobiol 26, 325-338 (1995).
21. Cheung NS, Small DH and Livett BG. J Neurochem 60, 1163-1166 (1993).
22. Monteggia LM, Arneric SP and Giordano T. Int J Dev Neurosci 12, 133-142 (1994).
23. Yankner BA, Duffy LK and Kirschner DA. Science 250, 279-282 (1990).
24. Alkondon M, Pereira EF, Wonnacott S et al. Mol Pharmacol 41, 802-808 (1992).
25. Alkondon M and Albuquerque EX. J Pharmacol Exp Ther 265, 1455-1473 (1993).
26. Ochoa EL, Li L and McNamee MG. Mol Neurobiol 4, 251-287 (1990).
27. Zorumski CF, Thio LL, Isenamee KE et al. Mol Pharmacol 41, 931-936 (1992).
28. Vibat CR, Lasalde JA, McNamee MG et al. Cell Mol Neurobiol 15, 411-425 (1995).
29. Peng X, Gerzanich V, Anand R et al. Mol Pharmacol 46, 523-530 (1994).
30. Takenouchi T and Munekata E. Neurosci Lett 173, 147-150 (1994).